IL17A and obesity disorder: Regarding the metabolic effects, disrupting the IL-17 pathway through genetic deletion (Il17a-/-) or blocking its signaling (Il17ra-/-) resulted in increased weight gain and adiposity in models of diet-induced obesity and MASLD (132, 133, 142).